• Donate
  • About Us
    • Marking 25 Years of Action Duchenne
    • Our Purpose
    • What We Do
    • Our Impact
    • Our Team
    • Work For Us
    • Volunteer
    • The DMD Registry
    • Action Duchenne Policies
  • Get Support
    • Register for Support
      • Time Out – A Space for Mums
      • Dads Against Duchenne
      • Grandparents Together
    • Recently diagnosed
    • Children and Young People
    • Schools
    • End of Life and Bereavement
  • Community Summit
    • Action Duchenne Community Summit 2026
    • Community Summit 2026 Agenda and Sponsors
    • Highlights from the Action Duchenne Conference 2025
  • News, Webinars and Blogs
    • News
    • Webinar Series 2026
    • Webinar recordings
    • Bite-Sized Duchenne Science Live
      • Facts about Duchenne muscular dystrophy
      • Signs and Symptoms of Duchenne Muscular Dystrophy
      • Diagnosis of Duchenne Muscular Dystrophy
      • Crucial Genetic Terminology
      • Genetics – Blueprint of Duchenne Muscular Dystrophy
      • How is Duchenne Muscular Dystrophy Inherited?
    • Hear From Our Community
  • Support Us
    • Friends of Action Duchenne
    • COMMUNITY BUSINESS PARTNERS: Creating Lasting Impact for Families Living with Duchenne
    • Side by Side: Running Together for Action Duchenne – Your Invitation
    • Upcoming Events and Challenges
    • Give in memory and help us support every family, every time.
    • You Do YOU – Fundraise Your Way
    • Fundraising at school
    • Donate by cheque and post
    • Welcome to our Runner Hub
  •  0 items - £0.00
  • Menu
  • Skip to right header navigation
  • Skip to main content
  • Skip to secondary navigation
  • Skip to footer

Before Header

  • My account
  •  0 items - £0.00

Action Duchenne

Header Right

  • Donate
  • About Us
    • Marking 25 Years of Action Duchenne
    • Our Purpose
    • What We Do
    • Our Impact
    • Our Team
    • Work For Us
    • Volunteer
    • The DMD Registry
    • Action Duchenne Policies
  • Get Support
    • Register for Support
      • Time Out – A Space for Mums
      • Dads Against Duchenne
      • Grandparents Together
    • Recently diagnosed
    • Children and Young People
    • Schools
    • End of Life and Bereavement
  • Community Summit
    • Action Duchenne Community Summit 2026
    • Community Summit 2026 Agenda and Sponsors
    • Highlights from the Action Duchenne Conference 2025
  • News, Webinars and Blogs
    • News
    • Webinar Series 2026
    • Webinar recordings
    • Bite-Sized Duchenne Science Live
      • Facts about Duchenne muscular dystrophy
      • Signs and Symptoms of Duchenne Muscular Dystrophy
      • Diagnosis of Duchenne Muscular Dystrophy
      • Crucial Genetic Terminology
      • Genetics – Blueprint of Duchenne Muscular Dystrophy
      • How is Duchenne Muscular Dystrophy Inherited?
    • Hear From Our Community
  • Support Us
    • Friends of Action Duchenne
    • COMMUNITY BUSINESS PARTNERS: Creating Lasting Impact for Families Living with Duchenne
    • Side by Side: Running Together for Action Duchenne – Your Invitation
    • Upcoming Events and Challenges
    • Give in memory and help us support every family, every time.
    • You Do YOU – Fundraise Your Way
    • Fundraising at school
    • Donate by cheque and post
    • Welcome to our Runner Hub

News

You are here: Home / News

Roche Announces Temporary Pause to New Orders of Delandistrogene Moxeparvovec To Key Countries Outside the US.

23 July 2025 by John Marrin

Today (23rd of July), Roche issued a community update regarding its Duchenne program, specifically addressing the availability of delandistrogene …

Roche Announces Temporary Pause to New Orders of Delandistrogene Moxeparvovec To Key Countries Outside the US.Read More

Edgewise Therapeutics Reports Positive Results on Sevasemten Program for Becker and Duchenne Muscular Dystrophies

27 June 2025 by Mehreen Arif

Edgewise Therapeutics has shared positive results in its Sevasemten program for Becker and Duchenne muscular dystrophies. Highlights include:● New …

Edgewise Therapeutics Reports Positive Results on Sevasemten Program for Becker and Duchenne Muscular DystrophiesRead More

Yes I Can Activity Day – Scotland

12 June 2025 by Lizzie Cox

Yes I Can Activity Day - Scotland Are you aged 12 and over, living with Duchenne and live in Scotland?  Join Action Duchenne in Scotland …

Yes I Can Activity Day – ScotlandRead More

Could you become a mentor for young people living with Duchenne?

6 June 2025 by Lizzie Cox

Do you have lived experience of Duchenne, have a skill you want to share, pass on practical tips about developing hobbies, moving into further …

Could you become a mentor for young people living with Duchenne?Read More

REGENXBIO reports new positive functional data from Phase I/II Affinity Duchenne Trial of RGX-202

6 June 2025 by Lizzie Cox

REGENXBIO announced new positive interim data from the Phase I/II AFFINITY DUCHENNE trial. Updates include positive functional, safety and biomarker …

REGENXBIO reports new positive functional data from Phase I/II Affinity Duchenne Trial of RGX-202Read More

PepGen Discontinues Development of PGN-EDO51 for Duchenne Muscular Dystrophy

29 May 2025 by John Marrin

We are sharing an important update with our community regarding PepGen Inc.'s investigational therapy, PGN-EDO51, for Duchenne muscular dystrophy …

PepGen Discontinues Development of PGN-EDO51 for Duchenne Muscular DystrophyRead More

Entrada Therapeutics Receives Authorisation for New DMD Clinical Trial in UK and Europe

29 May 2025 by John Marrin

Entrada Therapeutics, Inc., today announced a significant step forward in their Duchenne muscular dystrophy (DMD) clinical development programme. They …

Entrada Therapeutics Receives Authorisation for New DMD Clinical Trial in UK and EuropeRead More

European Medicines Agency Issues Positive Opinion on Givinostat

29 April 2025 by John Marrin

On the 25th of April, the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) gave Givinostat (Duvyzat) a …

European Medicines Agency Issues Positive Opinion on GivinostatRead More

MindJam – The Benefits and Possibilities of Gaming

25 April 2025 by Lizzie Cox

MindJam - The Benefits and Possibilities of Gaming MindJam provide emotional and SEN support for young people through gaming, game design and …

MindJam – The Benefits and Possibilities of GamingRead More

Expressing our gratitude to Pope Francis

22 April 2025 by Lizzie Cox

Following the sad news of the death of Pope Francis on 21st April 2025, we want to express our gratitude for the ongoing support he offered the …

Expressing our gratitude to Pope FrancisRead More

European Commission Confirms Decision Not to Renew the Market Authorisation for Translarna (Ataluren).

15 April 2025 by John Marrin

The European Commission (EC) has adopted the opinion of the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency …

European Commission Confirms Decision Not to Renew the Market Authorisation for Translarna (Ataluren).Read More

Roche’s update on clinical hold in Duchenne muscular dystrophy

4 April 2025 by Mehreen Arif

Roche’s update on clinical hold in Duchenne muscular dystrophy On the 18th March Sarepta announced the sad news regarding a young man with …

Roche’s update on clinical hold in Duchenne muscular dystrophyRead More

  • « Go to Previous Page
  • Page 1
  • Page 2
  • Page 3
  • Page 4
  • Page 5
  • Page 6
  • Interim pages omitted …
  • Page 49
  • Go to Next Page »

Footer

Action Duchenne
2nd Floor
South
One Castle Park
Tower Hill
Bristol
BS2 OJA

0300 102 1762
info@actionduchenne.org 

 

 

 

 

 

 

 

 

Subscribe to our mailing list

Do you consent to receiving regular email updates? *
Email Format
  • Accessibility
  • Privacy Policy
  • Terms & Conditions

Site Footer

Fundraising Regulator badge with validation link

© Action Duchenne - Registered Charity No 1101971 - Scottish Charity No SC043852